How reviews covered the unfolding scientific story of gabapentin for bipolar disorder

General Hospital Psychiatry

Volumn 31, Issue 3, 2009, Pages 279-287

  Williams Jr , John W ^a   Ranney, Leah ^b   Morgan, Laura C ^b   Whitener, Lynn ^b  

^a DUKE UNIVERSITY   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Bipolar disorder; Evidence based medicine; Gabapentin; Systematic review

Indexed keywords

GABAPENTIN;

ARTICLE; BIPOLAR DISORDER; DRUG ACTIVITY; DRUG EFFICACY; DRUG POTENTIATION; EVIDENCE BASED PRACTICE; FUNDING; HEALTH CARE POLICY; HUMAN; INFORMATION PROCESSING; MEDICAL RECORD REVIEW; MEDLINE; PHYSICIAN; PUBLICATION; QUALITY CONTROL; REFERENCE DATABASE;

AMINES; ANTIMANIC AGENTS; BIPOLAR DISORDER; CYCLOHEXANECARBOXYLIC ACIDS; GAMMA-AMINOBUTYRIC ACID; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 67349250196     PISSN: 01638343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.genhosppsych.2009.02.006     Document Type: Article

References (36)

1. Acharya N.V., Pickering R.M., Wilton L.W., and Shakir S.A. The safety and effectiveness of newer antiepileptics: a comparative postmarketing cohort study. J Clin Pharmacol 45 4 (2005) 385-393
2. Steinman M.A., Bero L.A., Chren M.M., and Landefeld C.S. Narrative review: the promotion of gabapentin: an analysis of internal industry documents. Ann Intern Med 145 4 (2006) 284-293
3. Goodman F., Glassman P., Maglione M., et al. Drug class review on antiepileptic drugs in bipolar mood disorder, neuropathic pain, and fibromyalgia, prepared by the Southern California Evidence-based Practice Center under contract to the Oregon Health and Science University for the Agency for Healthcare Research and Quality (2006)
4. Carey T.S., Williams J.W., Oldham J.M., et al. Gabapentin in the treatment of mental illness: the echo chamber of the case series. J Psychiatr Pract 14 Suppl 1 (2008) 15-34
5. Pande A.C., Crockatt J.G., Janney C.A., Werth J.L., and Tsaroucha G. Gabapentin in bipolar disorder: a placebo-controlled trial of adjunctive therapy. Gabapentin Bipolar Disorder Study Group. Bipolar Disord 2 3 Pt 2 (2000) 249-255
6. Frye M.A., Ketter T.A., Kimbrell T.A., et al. A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders. J Clin Psychopharmacol 20 6 (2000) 607-614
7. Obrocea G.V., Dunn R.M., Frye M.A., et al. Clinical predictors of response to lamotrigine and gabapentin monotherapy in refractory affective disorders. Biol Psychiatry 51 3 (2002) 253-260
8. Vieta E., Manuel Goikolea J., Martinez-Aran A., et al. A double-blind, randomized, placebo-controlled, prophylaxis study of adjunctive gabapentin for bipolar disorder. J Clin Psychiatry 67 3 (2006) 473-477
9. Botts S.R., and Raskind J. Gabapentin and lamotrigine in bipolar disorder. Am J Health Syst Pharm 56 19 (1999) 1939-1944
10. Bowden C.L. Novel treatments for bipolar disorder. Expert Opin Investig Drugs 10 4 (2001) 661-671
11. Calabrese J.R., Shelton M.D., Rapport D.J., and Kimmel S.E. Bipolar disorders and the effectiveness of novel anticonvulsants. J Clin Psychiatry 63 Suppl 3 (2002) 5-9
12. De Leon O.A. Antiepileptic drugs for the acute and maintenance treatment of bipolar disorder. Harv Rev Psychiatry 9 5 (2001) 209-222
13. Ernst C.L., and Goldberg J.F. Antidepressant properties of anticonvulsant drugs for bipolar disorder. J Clin Psychopharmacol 23 2 (2003) 182-192
14. Ferrier I.N. Lamotrigine and gabapentin. Alternative in the treatment of bipolar disorder. Neuropsychobiology 38 3 (1998) 192-197
15. Freeman M.P., and Stoll A.L. Mood stabilizer combinations: a review of safety and efficacy. Am J Psychiatry 155 1 (1998) 12-21
16. Gnanadesikan M., Freeman M.P., and Gelenberg A.J. Alternatives to lithium and divalproex in the maintenance treatment of bipolar disorder. Bipolar Disord 5 3 (2003) 203-216
17. Goodnick P.J. Anticonvulsants in the treatment of bipolar mania. Expert Opin Pharmacother 7 4 (2006) 401-410
18. Keck Jr. P.E., McElroy S.L., and Strakowski S.M. Anticonvulsants and antipsychotics in the treatment of bipolar disorder. J Clin Psychiatry 59 Suppl 6 (1998) 74-81 [discussion 82]
19. Letterman L., and Markowitz J.S. Gabapentin: a review of published experience in the treatment of bipolar disorder and other psychiatric conditions. Pharmacotherapy 19 5 (1999) 565-572
20. Macdonald K.J., and Young L.T. Newer antiepileptic drugs in bipolar disorder: rationale for use and role in therapy. CNS Drugs 16 8 (2002) 549-562
21. Mack A. Examination of the evidence for off-label use of gabapentin. J Manag Care Pharm 9 6 (2003) 559-568
22. Magnus L. Nonepileptic uses of gabapentin. Epilepsia 40 Suppl 6 (1999) S66-S72 [discussion S73-74]
23. Maidment I.D. Gabapentin treatment for bipolar disorders. Ann Pharmacother 35 10 (2001) 1264-1269
24. Muzina D.J., Elhaj O., Gajwani P., Gao K., and Calabrese J.R. Lamotrigine and antiepileptic drugs as mood stabilizers in bipolar disorder. Acta Psychiatr Scand Suppl 426 (2005) 21-28
25. Nemeroff C.B. An ever-increasing pharmacopoeia for the management of patients with bipolar disorder. J Clin Psychiatry 61 Supp 13 (2000) 19-25
26. Sachs G.S., and Cosgrove V.E. Bipolar disorder: current treatments and new strategies. Cleve Clin J Med 65 Suppl 1 (1998) SI31-SI37 [discussion SI45-47]
27. Shelton R.C. Treating bipolar depression. J Fam Pract Suppl (2003) S14-S17
28. Sussman N. Background and rationale for use of anticonvulsants in psychiatry. Cleve Clin J Med 65 Suppl 1 (1998) SI7-SI14 [discussion SI45-47]
29. Teter CJ, Early JJ. Novel pharmacotherapy for bipolar disorder. Pharmacy Times 2001;67:11-12, 15.
30. Yatham L.N. Newer anticonvulsants in the treatment of bipolar disorder. J Clin Psychiatry 65 Suppl 10 (2004) 28-35
31. Yatham L.N., Kusumakar V., Calabrese J.R., et al. Third generation anticonvulsants in bipolar disorder: a review of efficacy and summary of clinical recommendations. J Clin Psychiatry 63 4 (2002) 275-283
32. Janowsky D.S. New treatments of bipolar disorder. Curr Psychiatry Rep 1 2 (1999) 111-113
33. Aziz R., Lorberg B., and Tampi R.R. Treatments for late-life bipolar disorder. Am J Geriatr Pharmacother 4 4 (2006) 347-364
34. Carta M.G., Hardoy M.C., Hardoy M.J., Grunze H., and Carpiniello B. The clinical use of gabapentin in bipolar spectrum disorders. J Affect Disord 75 1 (2003) 83-91
35. Ghaemi S.N., and Gaughan S. Novel anticonvulsants: a new generation of mood stabilizers?. Harv Rev Psychiatry 8 1 (2000) 1-7
36. Atkins D., Eccles M., Flottorp S., et al. Systems for grading the quality of evidence and the strength of recommendations I: critical appraisal of existing approaches. The GRADE Working Group. BMC Health Serv Res 4 1 (2004) 38